On the mechanism and possible therapeutic application of delayed adaptation of the heart to stress situations
- PMID: 7494539
- DOI: 10.1007/BF00944791
On the mechanism and possible therapeutic application of delayed adaptation of the heart to stress situations
Abstract
Mild (not harmful) stress may initiate an adaptive mechanism, protecting the heart from harmful consequences of a more severe stress. There are at least three known types of cardiac adaptation to stress, such as: a) the gradually developing, long lasting adaptation to chronic mechanical overload, leading to cardiac hypertrophy, later to cardiomyopathy and heart failure, b) the rapidly developing adaptation to moderate stress initiated by 'preconditioning' brief coronary occlusion(s) or brief periods of rapid cardiac pacing, protecting for less than 1 h against consequences of a subsequent, severe stress, c) the later appearing, more prolonged cardio-protective adaptation, described by us in 1983, induced by various forms of more severe but not injurious stimuli, such as an optimal dose of prostacyclin or its stable analogues; or a series of brief periods of rapid pacings. This form of cardiac adaptation to stress protects for 24-48 h against consequences of a more severe stress such as: 1. myocardial ischaemia; 2. early and late postocclusion and reperfusion arrhythmias; 3. early morphologic changes secondary to ischaemia and reperfusion; 4. ischaemia induced myocardial loss of K+ and accumulation of Na+ and Ca++; 5. it may increase the tolerance to the toxic effects of cardiac glycosides. A reduced response to beta-adrenergic stimuli and a concomitant increase in activity and amount of PDE I and IV was shown by us earlier.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
On the mechanism and possible therapeutic application of delayed cardiac adaptation to stress.Can J Cardiol. 1996 Feb;12(2):177-85. Can J Cardiol. 1996. PMID: 8605640 Review.
-
Long lasting anti-adrenergic effect of 7-oxo-prostacyclin in the heart: a cycloheximide sensitive increase of phosphodiesterase isoform I and IV activities.Mol Cell Biochem. 1994 Mar 16;132(1):57-67. doi: 10.1007/BF00925675. Mol Cell Biochem. 1994. PMID: 8078509
-
Cardioprotection: endogenous protective mechanisms promoted by prostacyclin.Basic Res Cardiol. 1991;86 Suppl 3:215-21. doi: 10.1007/978-3-662-30769-4_21. Basic Res Cardiol. 1991. PMID: 1781766 Review.
-
Abrupt withdrawal of chronic beta-blockade: adaptive changes in cyclic AMP and contractility.J Mol Cell Cardiol. 1981 Nov;13(11):999-1009. doi: 10.1016/0022-2828(81)90475-2. J Mol Cell Cardiol. 1981. PMID: 6119366 No abstract available.
-
Drug-induced delayed cardiac protection against the effects of myocardial ischemia.Pharmacol Ther. 2005 Dec;108(3):269-80. doi: 10.1016/j.pharmthera.2005.04.007. Epub 2005 Aug 10. Pharmacol Ther. 2005. PMID: 16098598 Review.
Cited by
-
Adaptation of the heart to ischemia by preconditioning: effects on energy equilibrium, properties of sarcolemmal ATPases and release of cardioprotective proteins.Mol Cell Biochem. 1995 Jun 7-21;147(1-2):129-37. doi: 10.1007/BF00944793. Mol Cell Biochem. 1995. PMID: 7494541
-
Pharmacological induction of delayed and prolonged cardiac protection: The role of prostanoids.Exp Clin Cardiol. 2004 Spring;9(1):7-12. Exp Clin Cardiol. 2004. PMID: 19641689 Free PMC article.